(6-(Trifluoromethoxy)pyridin-3-yl)boronic acid, 95.0%, 25mg

Pyrazine-2,5-dicarbaldehyde, 95%, 50mg

n-Decano, mínimo 99 %, para síntesis, 100 ml, envase de vidrio

potassium trifluoro[(3-methylphenyl)methyl]boranuide, 95%, 5g

2-(Cyclopropylmethoxy)-3-methoxybenzaldehyde, 95+%, 5g

benzyl 3-acetylazetidine-1-carboxylate, 95.0%, 1g

2-CHLORO-4-NITROBENZONITRILE, 97.0%, 5g

3-Methyl-5-(trichloromethyl)-1,2,4-oxadiazole, 98+%, 1g

3-Ethoxybenzhydrazide, 98.0%, 1g

[1,1':4',1''-Terphenyl]-4,4''-dicarboxylic Acid, 95.0%, 1g

2-(1-methylindolin-5-yl)-2-(4-methylpiperazin-1-yl)ethan-1-amine, 95.0%, 2.5g

1,3-Diaminopropane Dihydrobromide>98.0%(N)(T)5g

7-chloro-2-(chloromethyl)-4H-pyrido[1,2-a]pyrimidin-4-one, 95.0%, 2.5g